Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 28, 2019 - Issue 4
Submit an article Journal homepage
269
Views
9
CrossRef citations to date
0
Altmetric
Review

Experimental therapies targeting apolipoprotein C-III for the treatment of hyperlipidemia – spotlight on volanesorsen

Dimitrios MilonasFirst Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, GreeceView further author information
&
Konstantinos TziomalosFirst Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, GreeceCorrespondence[email protected]
View further author information
Pages 389-394 | Received 23 Oct 2018, Accepted 10 Feb 2019, Published online: 15 Feb 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Cezary Wójcik. (2020) Emerging lipid lowering agents targeting LDL cholesterol. Postgraduate Medicine 132:5, pages 433-440.
Read now
Brian Tomlinson, Paul Chan, Yuzhen Zhang, Zhongmin Liu & Christopher Wai Kei Lam. (2020) Pharmacokinetics of current and emerging treatments for hypercholesterolemia. Expert Opinion on Drug Metabolism & Toxicology 16:5, pages 371-385.
Read now
David Rhainds, Mathieu R. Brodeur & Jean-Claude Tardif. (2019) Investigational drugs in development for hypertriglyceridemia: a coming-of-age story. Expert Opinion on Investigational Drugs 28:12, pages 1059-1079.
Read now

Articles from other publishers (6)

Vincenza Barresi, Camillo Musmeci, Alessandro Rinaldi & Daniele Filippo Condorelli. (2022) Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel Molecular Targets. International Journal of Molecular Sciences 23:16, pages 8875.
Crossref
Hai-Yang Li, Yan-Ling Yi, Sheng Guo, Fang Zhang, Hui Yan, Zhi-Lai Zhan, Yue Zhu & Jin-Ao Duan. (2022) Isolation, structural characterization and bioactivities of polysaccharides from Laminaria japonica: A review. Food Chemistry 370, pages 131010.
Crossref
Stanley T. Crooke, Xue-hai Liang, Rosanne M. Crooke, Brenda F. Baker & Richard S. Geary. (2021) Antisense drug discovery and development technology considered in a pharmacological context. Biochemical Pharmacology 189, pages 114196.
Crossref
Stanley T. Crooke, Brenda F. Baker, Rosanne M. Crooke & Xue-hai Liang. (2021) Antisense technology: an overview and prospectus. Nature Reviews Drug Discovery 20:6, pages 427-453.
Crossref
Brian Tomlinson, Chen-Hsiu Lin, Paul Chan & Christopher WK Lam. (2021) Personalized medicine in lipid-modifying therapy. Personalized Medicine 18:2, pages 185-203.
Crossref
Tejal Aslesh & Toshifumi Yokota. 2020. Gapmers. Gapmers 69 85 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.